BLU News and Press, BELLUS Health Inc. From 12/01/21

Gainers Cumberland Pharmaceuticals  (NASDAQ:CPIX) +111%. Adagene  (NASDAQ:ADAG) +12%. PLAYSTUDIOS (NASDAQ:MYPS) +7%. Verastem (NASDAQ:VSTM) +6%. Chimerix (NASDAQ:CMRX) +6%. Losers: BELLUS Health  (NASDAQ:BLU) -7%. LIZHI  (NASDAQ:LIZI) -6%. NRX Pharmaceuticals (NA...

Gainers: Cumberland Pharmaceuticals (NASDAQ:CPIX) +131%. Adagene (NASDAQ:ADAG) +12%. Chimerix (NASDAQ:CMRX) +11%. PLAYSTUDIOS (NASDAQ:MYPS) +8%. Verastem (NASDAQ:VSTM) +6%. Losers: BELLUS Health (NASDAQ:BLU) -7%. LIZHI (NASDAQ:LIZI) -5%. NRX Pharmaceuticals (NASDAQ:NRXP) -5%. G...

- Announced positive findings from the Phase 2b SOOTHE trial administrative interim analysis, with at least one dose of BLU-5937 meeting the threshold for a high probability of clinical efficacy - - Phase 2b SOOTHE and Phase 2a BLUEPRINT trials are fully enrolled, with topline...

- Live webcast to be held on November 15 th at 12:00 p.m. EST – BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of r...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Plowing through the most populated regions of the world like a hurricane, the novel coronavirus was and still is an unrelenting force. According to the time of writing data from Worldometers.info, 4.86 million people succum...

Most investors would agree that healthcare is one of the best sectors to find Canadian stocks to invest in, as there are several high-quality opportunities. Whether it’s a real estate stock that owns medical office buildings and hospitals, a pharmaceutical company with explosive ...

Evercore ISI has set up its list of key catalysts for the rest of 2021 in the biotechnology sector - including early-stage data readouts as well as some important legal and regulatory updates ahead for particular companies. Along the way it tees up its rule of thumb on biotech catalysts: "Alw...

Topline results from both studies are expected in December 2021 BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory c...

Gainers: MRIN +72.9%. ALPN +22.5%. SFIX +12.8%. PRAX +5.4%. LAUR +3.3%. Losers: SMMT -19.8%. LPTX -11.4%. BDSI -8.8%. BLU -5.2%. ATAX -4.2%. For further details see: MRIN, ALPN, SMMT and LPTX among after hours movers